However, the clinical evidence that HA may often affect multiple joints in the same patient and our current observation that circulating TNF-α is strongly increased and correlated with HA severity in hemophilia A patients might, instead, be in favor of a systemic anti-TNF-α therapeutic approach. Here, TNF is linked to hemophilia A.